Increase of anticoagulant and fibrinolytic activity of rat blood plasma when using products of velvet antler industry

Abstract

Aim. To evaluate the reaction of hemostatic system in rats on various duration of the intake of concentrated product containing blood and histolysate of Siberian stag reproductive organs, and to exclude the possible adaptive effect of additives (glucose, ascorbinic acid, fruit essences), contained in the used concentrate, on hemostatic system.

Methods. The study included 50 mature male Wistar rats. Three groups of experimental animals, including 10 rats each, received the concentrate containing blood and histolysate of the Siberian stag reproductive organs in the dose of 4.5 ml per day for 7, 14 and 30 days. Parameters obtained from the experimental animals were compared to those from intact rats and control group, receiving only additives, contained in the used concentrate.

Results. On day 7 of concentrate administration, the hemostatic parameters did not differ from those of intact rats. After 14 days of concentrate administration, decrease of fibrinogen concentration in blood and increase of anticoagulant activity of blood plasma were observed. On day 30 of concentrate intake, in addition to the earlier revealed changes in hemostatic system, hypocoagulation in the intrinsic pathway of plasma hemostasis activation and also increase of fibrinolytic activity of blood plasma were registered. Upon the expiration of 30 days of administration of additives, contained in the studied product, hemostatic parameters of the animals from the control group did not differ from those of intact rats.

Conclusion. Increase of adaptation of hemostatic system when taking the studied concentrate apparently involves increase of anticoagulant and fibrinolytic activity of rat blood plasma and reduction of fibrinogen concentration in the blood; the active component providing adaptive changes in the hemostatic system is the complex of biologically active substances contained in the blood and histolysate of the Siberian stag reproductive organs.

Keywords

fibrinolysis / anticoagulant activity of blood plasma / products of velvet antler industry

References

[1] Shakhmatov I.I., Vdovin V.M. Changes in hemostatic system in response to single physical loading of various intensities. Vestnik novykh meditsinskikh tekhnologiy. 2011; 18 (3): 207–209. (In Russ.)

[2] Шахматов И.И., Вдовин В.М. Изменения в системе гемостаза в ответ на однократную физическую нагрузку различной интенсивности. Вестн. новых мед. технол. 2011; 18 (3): 207-209.

[3] Momot A.P., Tsyvkina L.P., Taranenko I.A. et al. Sovremennye metody raspoznavaniya sostoyaniya tromboticheskoy gotovnosti. (Modern methods of recognition of a condition of trombotichesky readiness.) Barnaul: Izdatel’stvo AGU, 2011: 137 р. (In Russ.)

[4] Момот А.П., Цывкина Л.П., Тараненко И.А. и др. Современные методы распознавания состояния тромботической готовности. Барнаул: Издательство АГУ. 2011; 137 с.

[5] Produktsiya na osnove pantogematogena. Mekhanizmy deystviya i osobennosti primeneniya. (Products on the basis of antler hematogen. Mechanisms of action and peculiarities of administration.) Ed. by N.I. Suslov et al. Novosibirsk: Sibirskoe universitetskoe izdatel'stvo, 2008: 146 р. (In Russ.)

[6] Продукция на основе пантогематогена. Механизмы действия и особенности применения. Под ред. Н.И. Суслова и др. Новосибирск: Сибирское университетское издательство. 2008; 146 с.

[7] Zaitsev A.A., Barabash L.V., Smirnova I.N. et al. State of metabolic status of athletes on the background of intake of products of velvet antler industry. Lechebnaya fizkul'tura i sportivnaya meditsina. 2012; (8): 21–25. (In Russ.)

[8] Зайцев А.А., Барабаш Л.В., Смирнова И.Н. и др. Состояние метаболического статуса спортсменов на фоне приёма продуктов пантового мараловодства. Лечебная физкультура и спортивная мед. 2012; (8): 21-25.

[9] Jiang N., Zhang S., Zhu J. et al. Hypoglycemic, hypolipidemic and antioxidant effects of peptides from red deer antlers in streptozotocin-induced diabetic mice. Tohoku J. Experim. Med. 2015; 236 (1): 71–79. DOI: 10.1620/tjem.236.71.

[10] Jiang N., Zhang S., Zhu J. et al. Hypoglycemic, hypolipidemic and antioxidant effects of peptides from red deer antlers in streptozotocin-induced diabetic mice. Tohoku J. Experim. Med. 2015; 236 (1): 71-9. DOI: 10.1620/tjem.236.71.

[11] Zha E., Dandan L., Bai X. et al. A recombinant polypeptide from velvet antler of Cervus nippon Temminck exhibits similar immunomodulatory effects as its natural counterpart. Immunopharmacol. Immunotoxicol. 2016; 38 (6): 385–389. DOI: 10.1080/08923973.2016.1233978.

[12] Zha E., Dandan L., Bai X. et al. A recombinant polypeptide from velvet antler of Cervus nippon Temminck exhibits similar immunomodulatory effects as its natural counterpart. Immunopharmacol. Immunotoxicol. 2016; 38 (6): 385-389. DOI: 10.1080/08923973.2016.1233978.

[13] Jung E., Park Y., Woo M. et al. Hematopoietic effect of fermented deer antler extract in iron deficient diet-induced anemic rats. Chinese J. Integrative Med. 2016; 28: 1–6. DOI: 10.1007/s11655-016-2598-7.

[14] Jung E., Park Y., Woo M. et al. Hematopoietic effect of fermented deer antler extract in iron deficient diet-induced anemic rats. Chinese J. Integrative Med. 2016; 28: 1-6. DOI: 10.1007/s11655-016-2598-7.

[15] Semenov V.A., Latkov N.U., Koshelev U.A., Poznyakovskiy V.M. Application of pantohematogen in sports medical practice. Tekhnika i tekhnologiya pishchevykh proizvodstv. 2014; 2: 113–117. (In Russ.)

[16] Семёнов В.А., Латков Н.Ю., Кошелев Ю.А., Позняковский В.М. Применение пантогематогена в спортивно-медицинской практике. Техника и технология пищевых производств. 2014; 2: 113-117.

[17] Zharikov A.U., Lunitsyn V.G., Lampatov V.V. et al. Influence of new agents from raw materials of Fawn’s antlers on biosynthetic processes in rats skeletal muscle cells in conditions of long physical activity. Biomeditsina. 2016; (1): 90–94. (In Russ.)

[18] Жариков А.Ю., Луницын В.Г., Лампатов В.В. и др. Влияние новых средств из сырья пантовых оленей на биосинтетические процессы в клетках скелетной мускулатуры крыс в условиях длительной физической нагрузки. Биомедицина. 2016; (1): 90-94.

[19] Chen F., Yin J., Liu J. et al. Preparation and determination of insulin-like growth factor I in deer antler, heart and blood. J. Chinese Med. Materials. 2014; (12): 2155–2158. PMID: 26080495.

[20] Chen F., Yin J., Liu J. et al. Preparation and determination of insulin-like growth factor I in deer antler, heart and blood. J. Chinese Med. Materials. 2014; (12): 2155-2158. PMID: 26080495.

[21] Zhao L., Mi Y., Guan H. et al. Velvet antler peptide prevents pressure overload-induced cardiac fibrosis via transforming growth factor (TGF)-β1 pathway inhibition. Eur. J. Pharmacology. 2016; 783: 33–46. DOI: 10.1016/j.ejphar.2016.04.039.

[22] Zhao L., Mi Y., Guan H. et al. Velvet antler peptide prevents pressure overload-induced cardiac fibrosis via transforming growth factor (TGF)-β1 pathway inhibition. Eur. J. Pharmacology. 2016; 783: 33-46. DOI: 10.1016/j.ejphar.2016.04.039.

[23] Blazhko A.A., Shakhmatov I.I., Lycheva N.A., Moskalenko S.V. Risk reduction of thrombotic state of readiness under the influence of suprathreshold physical load in rats on the background of the anticipatory administration of pantohematogen. Sovremennie problemi nauki i obrazovaniya. 2016; (2). (In Russ.)

[24] Блажко А.А., Шахматов И.И., Лычева Н.А., Москаленко С.В. Снижение риска развития состояния тромботической готовности при воздействии сверхпороговой физической нагрузки у крыс на фоне предварительного приёма пантогематогена. Соврем. пробл. науки и образования. 2016; (2). DOI: 10.17513/spno.24255.

[25] Rukovodstvo po eksperimental'nomu (doklinicheskomu) izucheniyu novykh farmakologicheskikh veshchestv. (Handbook of experimental (preclinical) study of new drugs.) Ed. by R.U. Khabriev. Moscow: Medicina. 2005; 829 р. (In Russ.)

[26] Руководство по экспериментальному (доклиническому) изучению новых фармакологических веществ. Под ред. Р.У. Хабриева. М.: Медицина. 2005; 829 с.

[27] Commission of the European Communities, 86/609/ЕЕС. ISSN 03780 6978 (1986).

[28] Barkagan Z.S., Momot A.P. Diagnostika i kontroliruemaya terapiya narusheniy gemostaza. (Diagnosis and controlled therapy of hemostatic disorders.) Moscow: N'yudiamed, 2008: 292 р. (In Russ.)

[29] Баркаган З.С., Момот А.П. Диагностика и контролируемая терапия нарушений гемостаза. М.: Ньюдиамед. 2008; 292 с.

RIGHTS & PERMISSIONS

Blazhko A.A., Shakhmatov I.I., Zharikov A.Y., Kiselyov V.I.